Literature DB >> 9597363

Maternal drug use during pregnancy: are preterm and full-term infants affected differently?

J V Brown1, R Bakeman, C D Coles, W R Sexson, A S Demi.   

Abstract

This study examined whether preterm infants are more vulnerable to the effects of prenatal drug exposure than are full-term infants. The sample of 235 low-income African American mothers and their infants included 119 cocaine-polydrug users, 19 alcohol-only users, and 97 nonusers; 148 infants were full term and 87 were preterm. Direct effects of exposure on birth weight, birth length, ponderal index, and irritability were moderated by length of gestation: Fetal growth deficits were more extreme in later-born infants, whereas increases in irritability were more extreme in earlier born infants. Effects of exposure on cardiorespiratory reactivity to a neonatal exam were not moderated by length of gestation. In general, effects of exposure occurred for both cocaine-polydrug and alcohol only users and so could not be unambiguously attributed to either of these drugs alone.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9597363     DOI: 10.1037//0012-1649.34.3.540

Source DB:  PubMed          Journal:  Dev Psychol        ISSN: 0012-1649


  22 in total

1.  Increased "default mode" activity in adolescents prenatally exposed to cocaine.

Authors:  Zhihao Li; Priya Santhanam; Claire D Coles; Mary Ellen Lynch; Stephan Hamann; Scott Peltier; Xiaoping Hu
Journal:  Hum Brain Mapp       Date:  2011-05       Impact factor: 5.038

2.  Prenatal cocaine use and maternal depression: effects on infant neurobehavior.

Authors:  Amy L Salisbury; Barry M Lester; Ronald Seifer; Linda Lagasse; Charles R Bauer; Seetha Shankaran; Henrietta Bada; Linda Wright; Jing Liu; Ken Poole
Journal:  Neurotoxicol Teratol       Date:  2006-12-14       Impact factor: 3.763

3.  Neonatal abstinence syndrome--postnatal ward versus neonatal unit management.

Authors:  Tolulope Saiki; Silke Lee; Simon Hannam; Anne Greenough
Journal:  Eur J Pediatr       Date:  2009-05-14       Impact factor: 3.183

4.  Longitudinal changes of amygdala and default mode activation in adolescents prenatally exposed to cocaine.

Authors:  Zhihao Li; Claire D Coles; Mary Ellen Lynch; Yuejia Luo; Xiaoping Hu
Journal:  Neurotoxicol Teratol       Date:  2015-11-11       Impact factor: 3.763

5.  Effects of prenatal cocaine exposure on infant reactivity and regulation.

Authors:  Rina D Eiden; Shannon McAuliffe; Lorig Kachadourian; Claire Coles; Craig Colder; Pamela Schuetze
Journal:  Neurotoxicol Teratol       Date:  2008-09-10       Impact factor: 3.763

6.  Conceptual model for maternal behavior among polydrug cocaine-using mothers: the role of postnatal cocaine use and maternal depression.

Authors:  Rina D Eiden; Arianne Stevens; Pamela Schuetze; Laura E Dombkowski
Journal:  Psychol Addict Behav       Date:  2006-03

7.  Recursive cluster elimination based support vector machine for disease state prediction using resting state functional and effective brain connectivity.

Authors:  Gopikrishna Deshpande; Zhihao Li; Priya Santhanam; Claire D Coles; Mary Ellen Lynch; Stephan Hamann; Xiaoping Hu
Journal:  PLoS One       Date:  2010-12-09       Impact factor: 3.240

8.  Prenatal cocaine exposure alters emotional arousal regulation and its effects on working memory.

Authors:  Zhihao Li; Claire D Coles; Mary Ellen Lynch; Stephan Hamann; Scott Peltier; Stephen LaConte; Xiaoping Hu
Journal:  Neurotoxicol Teratol       Date:  2009-08-21       Impact factor: 3.763

9.  Multifocal multi-organ ischaemia and infarction in a preterm baby due to maternal intravenous cocaine use: a case report.

Authors:  Ben C Reynolds; Dawn Km Penman; Allan G Howatson; Lesley A Jackson; Charles H Skeoch
Journal:  J Med Case Rep       Date:  2009-09-14

10.  Multifocal multi-organ ischaemia and infarction in a preterm baby due to maternal intravenous cocaine use: a case report.

Authors:  Ben C Reynolds; Dawn Mk Penman; Allan G Howatson; Lesley A Jackson; Charles H Skeoch
Journal:  J Med Case Rep       Date:  2009-12-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.